Preview of Molecular Med TRI-CON 2017

A Presentation from Core Informatics

The Cambrian explosion, a brief but powerfully significant evolutionary event that occurred approximately 550 million years ago, increased the biological diversity on earth by at least an order of magnitude and was perhaps the fastest growth of major new animals ever recorded. Ramifications from this relatively short geological time frame paved the way for life as we know it today.

Advancement in modern medicine, especially the convergence between big data and high throughput genomics, is arguably driving the neo “Cambrian Healthcare Explosion.” This vertex between big data and medicine is creating a landscape from which new tools for healthcare are being developed and our understanding of complex biology and disease is increased. Our ability to target and ameliorate the genetic underlining defects in diseases is unprecedented.

Despite improvements in laboratory technology and drug discovery the cost of developing a new drug roughly doubles every nine years. Drug discovery is becoming more expensive over time - a phenomenon known as “Eroom’s law”; which is intentionally Moore’s law spelled backwards to highlight the slowing of new innovation.

A Closer Look at Core’s TRI-CON Presentation

Please come see my talk at Molecular Med TRI-CON 2017 on the ways an informatics platform can address the challenges faced by scientists and increase R&D efficiency - including how Core’s Platform for Science empowers scientists to discover insights hidden in data, manage collaborations, unify data across multiple sources, and make challenging scientific problems more clear and solvable.

This presentation will contain a multi-faceted and bench to bedside approach that bridges discovery and development, and includes research findings from transcriptomics, proteomics, preclinical, to clinical research in patient populations.

Core Blog Note: Marc Siladi’s presentation, “The Paradigm Shift in Integrated Informatics,” is in TRI-CON’s "Integrated Informatics for Collaboration, Decision Making, and Precision Medicine" track on Monday, February 20th.

Marc Siladi is a Senior Business Analyst for Core Informatics. Before joining Core Informatics, Marc was a Research Scientist at Vertex Pharmaceuticals with hands on involvement in innovative drug discovery efforts to benefit patients with deadly diseases. Prior to Vertx, Marc worked at Ambrx, and The Scripps Research Institute.